Compare Lowe`s Companies Inc (LOW) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lowe`s Companies Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Lowe`s Companies Inc trades at $221.25 (market cap $124.06B), while State Street SPDR S&P Biotech ETF trades at $158.2. The key difference: Lowe`s Companies Inc pays a 2.26% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Lowe`s Companies Inc nearer its low. Which is the better fit depends on your goals.
| LOW | XBI | |
|---|---|---|
Market Cap | $124.06B | — |
Sector | Consumer Cyclical | Broad Market / Factor |
52-Week High | $287.39 | $164.28 |
52-Week Low | $201.92 | $86.92 |
Enterprise Value | $165.81B | — |
Dividend Yield | 2.26% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Lowe`s Companies Inc
Lowe's is the second-largest home improvement retailer in the world, operating 1,969 stores and servicing around 230 dealer-owned stores throughout the United States and Canada. The firm's stores offer products and services for home decorating, maintenance, repair, and remodeling, with maintenance and repair accounting for two thirds of products sold. Lowe's targets retail do-it-yourself (around 75% of sales) and do-it-for-me customers as well as commercial and professional business clients (around 25% of sales). We estimate Lowe's captures a low-double-digit share of the domestic home improvement market, based on U.S. Census data and management's estimates for market size.
Read more on LOW →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
